Effect of L-DOPA on depression. 1969

W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
September 1969, Lancet (London, England),
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
September 1970, Lancet (London, England),
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
May 1977, Journal of the American Geriatrics Society,
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
January 1977, Advances in biochemical psychopharmacology,
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
July 1970, Journal of the American Geriatrics Society,
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
September 1976, Current therapeutic research, clinical and experimental,
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
July 1973, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
January 2000, The Journal of laboratory and clinical medicine,
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
August 1970, Lancet (London, England),
W E Bunney, and D S Janowsky, and F K Goodwin, and J M Davis, and H K Brodie, and D L Murphy, and T N Chase
August 1970, Lancet (London, England),
Copied contents to your clipboard!